Reviews

Heinbockel L, Weindl G, Martinez-de-Tejada G, Correa W, Sanchez-Gomez S, Bárcena-Varela S, Goldmann T, Garidel P, Gutsmann T, Brandenburg K (2018) Inhibition of lipopolysaccharide- and lipoprotein-induced inflammation by antitoxin peptide Pep19-2.5. Front Immunol. 9: 1704. DOI: 10.3389/fimmu.2018.01704

Pfalzgraff A, Brandenburg K, Weindl G (2018) Antimicrobial peptides and their therapeutic potential for bacterial skin infections and wounds. Front Pharmacol. 9: 281. DOI: 10.3389/fphar.2018.00281

Said A, Weindl G (2015) Regulation of dendritic cell function in inflammation. J Immunol Res. 2015: 743169. DOI: 10.1155/2015/743169 (invited)

Gauglitz GG, Callenberg H, Weindl G, Korting HC (2012) Host Defence Against Candida albicans and the Role of Pattern-recognition Receptors. Acta Derm Venereol. 92: 291-298. DOI: 10.2340/00015555-1250

Weindl G, Wagener J, Schaller M (2011) Interaction of the mucosal barrier with accessory immune cells during fungal infection. Int J Med Microbiol. 301: 431-435. DOI: 10.1016/j.ijmm.2011.04.011 (invited)

Weindl G, Wagener J, Schaller M (2010) Epithelial cells and innate antifungal defense. J Dent Res. 89: 666-675. DOI: 10.1177/0022034510368784 (invited)

Schaller M, Zakikhany K, Weindl G, Borelli C, Korting HC, Hube B (2008) [Characterization of the interaction between Candida albicans and host cells: In vitro model using reconstituted human skin and mucosa]. [Article in German]. Hautarzt. 59: 964-970. DOI: 10.1007/s00105-008-1549-4 (invited)

Mukherjee S, Date AA, Patravale V, Korting HC, Roeder A, Weindl G (2006) Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging. 1: 327-348. Full text (invited)

Weindl G, Roeder A, Schäfer-Korting M, Schaller M, Korting HC (2006) Receptor-Selective Retinoids for Psoriasis: Focus on Tazarotene. Am J Clin Dermatol. 7: 85-97. DOI: 10.2165/00128071-200607020-00002 (invited)

Weindl G, Schäfer-Korting M, Schaller M, Korting HC (2005) Peroxisome proliferator-activated receptors and their ligands: entry into the post-glucocorticoid era of skin treatment? Drugs. 65: 1919-1934. DOI: 10.2165/00003495-200565140-00002

Roeder A, Kirschning CJ, Rupec RA, Schaller M, Weindl G, Korting HC (2004) Toll-like receptors as key mediators in innate antifungal immunity. Med Mycol. 46: 486-498. DOI: 10.1080/13693780400011112

Weindl G, Schaller M, Schäfer-Korting M, Korting HC (2004) Hyaluronic acid in the treatment and prevention of skin diseases: molecular biological, pharmaceutical and clinical aspects. Skin Pharmacol Physiol. 17: 207-213. DOI: 10.1159/000080213